CD28 and cancer: Then, the human peripheral blood T lymphocytes were co-cultured with cancer cells (F2-H3) supplying the CD28 signal for 48 h, and subsequently the T-cell repertoire was separated into targeted activation group (T-F2-H3) and non-targeted group (T-control) by flow cytometry sorting.